A thiazepino[4,5-a]benzimidazole derivative hampers the RNA replication of Eurasian serotypes of foot-and-mouth disease virus
Authors:
- David J. LefebvreDLDavid J. Lefebvre
- Annebel R. De VleeschauwerAVAnnebel R. De Vleeschauwer
- Nesya GorisNGNesya Goris
- Steven Van BormSBSteven Van Borm
- Alba ChimirriACAlba Chimirri
- Anna Maria MonforteAMAnna Maria Monforte
- Begona Valdazo-GonzalezBVBegona Valdazo-Gonzalez
- Donald P. KingDKDonald P. King
- Johan NeytsJNJohan Neyts
- Kris De ClercqKCKris De Clercq
- 1 December 2014
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 455 (3-4) , 378-381
Abstract
No abstract availableKeywords
Funding Information
- European Community’s Seventh Framework Program
- Belgian Federal Public Service of Health, Food Chain Safety and Environment
- European Community’s Sixth Framework Program
- Department for Environment, Food and Rural Affairs
This publication has 29 references indexed in Scilit:
- Repeated exposure to 5D9, an inhibitor of 3D polymerase, effectively limits the replication of foot-and-mouth disease virus in host cellsAntiviral Research, 2013
- Novel Antiviral Therapeutics to Control Foot-and-Mouth DiseaseJournal of Interferon & Cytokine Research, 2012
- Bovine Type III Interferon Significantly Delays and Reduces the Severity of Foot-and-Mouth Disease in CattleJournal of Virology, 2012
- Porcine Type I Interferon Rapidly Protects Swine Against Challenge with Multiple Serotypes of Foot-and-Mouth Disease VirusJournal of Interferon & Cytokine Research, 2011
- Inhibition of Foot-and-Mouth Disease Virus Infections in Cell Cultures with Antisense Morpholino OligomersJournal of Virology, 2007
- 2′-C-Methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virusAntiviral Research, 2007
- Protection of Balb/c mice against infection with FMDV by immunostimulation with CpG oligonucleotidesAntiviral Research, 2006
- Adenovirus-Mediated RNA Interference against Foot-and-Mouth Disease Virus Infection both In Vitro and In VivoJournal of Virology, 2006
- Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak responseVaccine, 2005
- Estudio de la selección de cepas vacunales contra la fiebre aftosaScientific and Technical Review, 2005